Literature DB >> 2484753

Serum zinc and copper in patients with atherosclerosis and thromboangiitis obliterans.

G Uza1, R Vlaicu.   

Abstract

The serum concentration of Zn and Cu were determined in 126 controls and 160 patients with atherosclerosis obliterans (AO) and 53 patients with thromboangiitis obliterans (TO). The concentration of serum Zn decreases with age both in controls and patients with AO in all the evolutive stages of the disease. In patients with TO, the concentration of serum Zn shows no correlation with age. The significantly lower values of serum Zn in controls and patients with AO over 61 yr than those below this age is attributed to the decreased Zn supply, especially to some individual cellular abnormalities. The values of serum Cu are higher in patients with AO and TO than in controls irrespective of the evolutive stage of the disease. This was related to cigarette smoking and inflammation. The Zn/Cu ratio in the serum is below 1 in patients with AO and TO and in controls over 61-yr-old. The pathogenetic role of this ratio in atherosclerosis and inflammation still remains a controversial question.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2484753     DOI: 10.1007/bf02917435

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  12 in total

Review 1.  Oral ulceration and Behçet's syndrome.

Authors:  T Lehner
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

2.  Serum copper in peripheral vascular diseases.

Authors:  J D Khandekar; G C Sepaha; D P Mukerji
Journal:  N Engl J Med       Date:  1970-08-06       Impact factor: 91.245

3.  [Serum zinc and copper in patients with atherosclerosis obliterans of the lower limbs].

Authors:  C Uza; A Kovacs; R Vlaicu
Journal:  Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna       Date:  1982 Nov-Dec

4.  Reduced serum zinc levels and oral zinc supplementation in geriatric patients.

Authors:  C W Wilson; L Myskow
Journal:  Int J Vitam Nutr Res       Date:  1985       Impact factor: 1.784

5.  Metabolic and cardiovascular abnormalities in patients with peripheral arterial disease.

Authors:  J K Vyden; J Thorner; K Nagasawa; T Takano; M F Groseth-Dittrich; R Perlow; H J Swan
Journal:  Am Heart J       Date:  1975-12       Impact factor: 4.749

6.  Serum zinc and copper in hyperlipoproteinemia.

Authors:  G Uza; S Gabor; A Kovats; R Vlaicu; M Cucuianu
Journal:  Biol Trace Elem Res       Date:  1985-11       Impact factor: 3.738

Review 7.  Copper deficiency in humans.

Authors:  D M Williams
Journal:  Semin Hematol       Date:  1983-04       Impact factor: 3.851

8.  Trace minerals and atherosclerosis.

Authors:  W Mertz
Journal:  Fed Proc       Date:  1982-09

9.  [Copper pathology (author's transl)].

Authors:  B Mallet; J Romette; J D Di Costanzo
Journal:  Nouv Presse Med       Date:  1982-01-30

10.  [The effect of various diseases on the zinc plasma level].

Authors:  P Pras; J M Bayada; F Bertrand; P Lapalus; R Garaffo; E C Savini; P Babeau
Journal:  Sem Hop       Date:  1983-05-19
View more
  4 in total

1.  Effect of copper sulfate on experimental atherosclerosis.

Authors:  M Vlad; E Bordas; R Tomus; D Sava; E Farkas; G Uza
Journal:  Biol Trace Elem Res       Date:  1993-07       Impact factor: 3.738

Review 2.  Neuroendocrine-immune aspects of accelerated aging in rheumatoid arthritis.

Authors:  Peter Härle; Rainer H Straub
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

3.  Zinc content of normal human serum and its correlation with some hematic parameters.

Authors:  M Folin; E Contiero; G M Vaselli
Journal:  Biometals       Date:  1994-01       Impact factor: 2.949

4.  Effects of zinc on copper-induced and spontaneous lipid peroxidation.

Authors:  P M Filipe; A C Fernandes; C F Manso
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.